Indoco Remedies Limited (NSE: INDOCO), ISIN INE873D01024 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
INDOCO last traded at ₹225.15 (-1.29%), with a 52-week range of ₹163.70 to ₹332.15 (as of 30 Jul 2026).
Shareholding as of Jun 2026: promoters 58.86%, FIIs 1.27%, DIIs 17.68%, mutual funds 17.16%.
EquiSense Score (ECS): 66/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.